A Study of MRG003 in the Treatment of EGFR-positive Unresectable, Locally Advanced or Metastatic Biliary Tract Cancer

NCT04838964 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
80
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Shanghai Miracogen Inc.